Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Date

20 October 2022

Indonesiƫ verbiedt verkoop mogelijk giftige hoestsiroop na dood 99 kinderen

Direct links

Read the article

In an article for the Dutch de Volkskrant, the Foundation's Research Programme Manager,Ā Claudia MartĆ­nez, speaks about the vulnerable position of low- and middle-income countries in the global medication chain.Ā 

"Veel arme landen hebben de expertise en capaciteit niet om te controleren welke medicijnen het land binnenkomen. Of ze beschikken niet over de juiste laboratoria om te blijven testen en monitoren."

The article discusses the temporary ban on the sale of potentially toxic cough syrup in Indonesia following the death of 99 children.Ā Earlier in the month, 70 children in The Gambia died after ingesting a syrup containing high doses of diethylene glycol and ethylene glycol. The Indonesian authorities are working with the World Health Organization (WHO) to find out how the drugs came on the market and whether there is a link with the drugs that caused the deaths of children in The Gambia.

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved